291, Novartis Investigational vaccine — Spartanburg, South Carolina

291, Novartis Investigational vaccine is a clinical research site located in Spartanburg, South Carolina, United States 27262.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

291, Novartis Investigational vaccine has participated in 1 clinical trials.

Therapeutic areas: Influenza Virus.

Sponsors: Seqirus.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Spartanburg

Browse all research sites in South Carolina · View every site in Spartanburg

• Spartanburg Regional Hospital NFP
• Cardiology Consultants PA, Spartanburg Regional Hospital
• Mary Black Memorial Hospital
• Spartanburg Regional Hospital
• Spartanburg Medical Center
• CCOP, Upstate Carolina
• Gibbs Regional Cancer Center at Spartanburg Regional Medical Center
• GSK Investigational Site
• Spartanburg Medical Research
• Research Site
• Spartanburg Regional Medical Center
• Greenville Health System Cancer Institute-Spartanburg

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for 291, Novartis Investigational vaccine?

291, Novartis Investigational vaccine has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has 291, Novartis Investigational vaccine conducted?

291, Novartis Investigational vaccine has 1 clinical trials on record. Their work covers Influenza Virus.

Is 291, Novartis Investigational vaccine accredited by Crixeo Clinical Trials?

291, Novartis Investigational vaccine has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about 291, Novartis Investigational vaccine?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.